ESR1 and colorectal cancer: In addition, WDR43 has been implicated in the development of human estrogen receptor-negative breast cancer and identified as a possible therapeutic target for colorectal cancer (Couch et al., 2016; Bi et al., 2019; Li et al., 2021; Sun et al., 2022).